Drug intelligence / Profile preview

xiao'er fuxie ning tangjiang

Development stage
Unknown
Lead developer
Shandong Kongfu Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Xiao'er Fuxie Ning Tangjiang is a Traditional Chinese Medicine (TCM) syrup developed and manufactured by Shandong Kongfu Pharmaceutical for the treatment of pediatric diarrhea. The formulation is specifically indicated for diarrhea caused by spleen and stomach weakness (pi wei xu ruo), characterized by symptoms such as loose, pale stools, lack of odor, sallow complexion, and fatigue. It is composed of a synergistic blend of herbal extracts, including Puerariae Lobatae Radix (Gegen), Pogostemonis Herba (Guanghuoxiang), Poria (Fuling), Coicis Semen (Yiyiren), Platycodonis Radix (Jiegeng), and Glycyrrhizae Radix (Gancao). These ingredients work together to harmonize the stomach, strengthen the spleen's transportive function, and regulate gastrointestinal motility to arrest diarrhea. The product is an approved pharmaceutical in China (NMPA approval 国药准字Z37021318) and is administered orally.

Brand names
Xiao'er Fuxie Ning Tangjiang
Other names
小儿腹泻宁糖浆Xiaoer Fuxiening Tangjiang

Beyond the preview

Go deeper on xiao'er fuxie ning tangjiang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiao'er fuxie ning tangjiang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call